U.S., Jan. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07343648) titled 'Assessment of Antithyroglobulin Antibody Levels Among Diabetic Patients' on Jan. 07.
Brief Summary: Assessment of antithyroglobulin antibody (anti Tg) level among diabetic patients explores the intersection between autoimmune thyroid disease and diabetes mellitus. Autoimmune thyroiditis and diabetes frequently coexist, and anti Tg is one of the main markers used to document thyroid autoimmunity.(1,2) Thyroglobulin is a large iodinated glycoprotein produced by thyroid and serves as the precursor for thyroid hormone synthesis. Damage to thyroid tissue in autoimmune thyroiditis leads to production of autoantibodies against thyroglobuli...